Suven Life Sciences Limited, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1989, the company has established itself as a leader in drug discovery and development, focusing on central nervous system disorders and other therapeutic areas. With a robust portfolio of innovative products and services, Suven Life Sciences is renowned for its unique approach to developing novel compounds that address unmet medical needs. The company has achieved significant milestones, including successful collaborations and partnerships that enhance its market position. Operating primarily in India and expanding its reach globally, Suven Life Sciences continues to make strides in the industry, driven by a commitment to research excellence and patient-centric solutions.
How does Suven Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Suven Life Sciences Limited's score of 14 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Suven Life Sciences Limited reported total carbon emissions of approximately 864,567 kg CO2e, comprising 31,483 kg CO2e from Scope 1 and 833,084 kg CO2e from Scope 2. This represents a slight decrease from 2022, where total emissions were about 890,219 kg CO2e, with Scope 1 emissions at 31,101 kg CO2e and Scope 2 emissions at 859,118 kg CO2e. For 2024, the company anticipates further reductions, with projected emissions of around 888,615 kg CO2e, including 30,539 kg CO2e from Scope 1 and 858,076 kg CO2e from Scope 2. Despite these figures, Suven Life Sciences has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to focus on managing its emissions as part of its broader commitment to sustainability and environmental responsibility.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | 2024 | |
---|---|---|---|
Scope 1 | 31,101 | 00,000 | 00,000 |
Scope 2 | 859,118 | 000,000 | 000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Suven Life Sciences Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.